ERCC1 and ovarian carcinoma: High ERCC1 expression at the mRNA or protein level has been linked in many studies with poor response to chemotherapy: non-small cell lung carcinoma [5–8]; squamous cell carcinoma [9, 10]; and ovarian cancer [11].